pISSN 2636-0004eISSN 2636-0012
pISSN 2636-0004Patient Demographics, Characteristics, and Perioperative Data
| Perioperative data | TACE-LR ( |
LR ( |
LR-matching ( |
||
|---|---|---|---|---|---|
| TACE-LR vs. LR | TACE-LR vs. LR-matching | ||||
| Age (yr) | 56.27 ± 10.8 | 60.26 ± 11.15 | 51.59 ± 10.76 | 0.056 | 0.066† |
| Gender, man | 32 (86.49) | 101 (82.11) | 33 (89.19) | 0.534 | 1.000* |
| MELD score | 8.11 ± 2.58 | 8.14 ± 3.07 | 8.16 ± 3.12 | 0.96 | 0.94 |
| T staging (AJCC, 8th edition) | 0.71 | 0.61 | |||
| T1a | 7 | 24 | 2 | ||
| T1b | 21 | 81 | 21 | ||
| T2 | 8 | 15 | 11 | ||
| T3 | 1 | 3 | 3 | ||
| Location of the tumor | 0.65 | 0.61 | |||
| Right lobe | 24 | 69 | 24 | ||
| Left lobe | 7 | 38 | 9 | ||
| Bi lobe | 6 | 16 | 4 | ||
| Number of tumors | 1.30 ± 0.57 | 1.16 ± 0.43 | 1.43 ± 0.65 | 0.11 | 0.34 |
| Size of the tumor | 5.10 ± 3.41 | 4.21 ± 3.2 | 6.18 ± 4.49 | 0.14 | 0.25 |
| Major hepatectomy | 16 (43.24) | 21 (17.07) | 12 (32.43) | 0.001 | 0.338 |
| Length of hospital stay (median, IQR) | 8 (7–11) | 7 (6–9) | 7 (6–9) | 0.005‡ | 0.017‡ |
| Operative time (median, IQR) | 300 (255–360) | 285 (240–360) | 290 (270–405) | 0.176‡ | 0.824‡ |
| Blood loss (median, IQR) | 800 (500–1,200) | 500 (200–1,000) | 500 (300–1,000) | 0.013‡ | 0.148‡ |
| LPPRC transfusion | 16 (43.24) | 38 (30.89) | 11 (29.73) | 0.164 | 0.227 |
| FFP transfusion | 8 (21.62) | 22 (17.89) | 8 (21.62) | 0.610 | 1.000 |
| PLT transfusion | 4 (10.81) | 8 (6.50) | 3 (8.11) | 0.475* | 1.000* |
| Complications | 9 (24.32) | 17 (13.82) | 5 (13.51) | 0.129 | 0.235 |
| Major morbidity (CD grade III/IV) | 4 (10.81) | 4 (3.25) | 2 (5.41) | 0.084* | 0.674* |
| Mortality | 1 (2.70) | 1 (0.81) | 0 (0.00) | 0.410* | 1.000* |
| Positive R1 status | 3 (8.11) | 8 (6.50) | 3 (8.11) | 0.717* | 1.000* |